Advertisement

Topics

Fatal Insomnia - Biotech, Pharma and Life Science Channel

01:58 EDT 25th March 2017 | BioPortfolio

PubMed Articles [831 Associated PubMed Articles listed on BioPortfolio]

Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice.

Registries and non-interventional studies offer relevant and complementary information to clinical trials, since they have a high external validity. Areas covered: The information regarding the effica...

Resisting fatal attraction: a glioma oncometabolite prevents CD8+ T cell recruitment.

Immunotherapy has emerged as a potent approach for treating aggressive cancers, such as non-small-cell lung tumors and metastatic melanoma. Clinical trials are now in progress for patients with malign...

Infections in Patients with a Total Artificial Heart are Common but Rarely Fatal.

Patients who received a total artificial heart (TAH) at Virginia Commonwealth University (VCU) between January 1, 2010 and December 31, 2011 were identified from the VCU Mechanical Circulatory Support...

Sleep-wake disturbances after traumatic brain injury: Synthesis of human and animal studies.

Sleep-wake disturbances following traumatic brain injury (TBI) are increasingly recognized as a serious consequence following injury and as a barrier to recovery. Injury-induced sleep-wake disturbance...

A unified model of the hierarchical and stochastic theories of gastric cancer.

Gastric cancer (GC) is a life-threatening disease worldwide. Despite remarkable advances in treatments for GC, it is still fatal to many patients due to cancer progression, recurrence and metastasis. ...

Measures to Prevent Air Embolism in Transthoracic Biopsy of the Lung.

Systemic air embolism (AE) is a rare but feared complication of transthoracic biopsy with potentially fatal consequences. The aim of the study was to assess the effect of patient positioning during tr...

Shorter sleep duration is associated with social impairment and comorbidities in ASD.

Sleep disturbance, particularly insomnia, is common in children with autism spectrum disorders (ASD). Furthermore, disturbed sleep affects core symptoms and other related comorbidities. Understanding ...

Higher Prevalence of Frailty Among a Sample of HIV-Infected Middle-aged and Older Chinese Adults Is Associated With Neurocognitive Impairment and Depressive Symptoms.

We investigated the prevalence and correlates of prefrailty/frailty, determined on the basis of the Fried criteria, in Chinese patients with and those without human immunodeficiency virus (HIV) infect...

In-silico design, expression, and purification of novel chimeric Escherichia coli O157:H7 OmpA fused to LTB protein in Escherichia coli.

E. coli O157:H7, one of the major EHEC serotypes, is capable of developing bloody diarrhea, hemorrhagic colitis (HC), and fatal hemolytic uremic syndrome (HUS) and is accompanied by high annual econom...

The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking.

The orexin/hypocretin system is important for appetitive motivation towards multiple drugs of abuse, including nicotine. Both OX1 and OX2 receptors individually have been shown to influence nicotine s...

News Articles [585 Associated News Articles listed on BioPortfolio]

Collaboration Announced Between Somnology, Inc. and National Institute of Health

Today, over 70 million in the domestic U.S. have sleep disorders. International health organizations report globally those afflicted with sleep disorders approximate 1 billion. El...

FDA fast-tracks Genentech’s Rituxan

Brian BerkDrug is intended for the treatment of pemphigus vulgaris, a painful, disfiguring and potentially fatal autoimmune disease characterized by progressive blistering of skin and/or mucous membra...

Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo (nivolumab) for the Treatment of Squamous Cell Cancer of the Head and Neck in Adults Progressing on or After Platinum-based Therapy

First Immuno-Oncology agent to receive positive CHMP opinion for the treatment of an advanced form of head and neck cancer Positive opinion based on overall survival bene...

Oklahoma City PAINWeekEnd: Pain Management CE/CME Conference for The Main Street Practitioner on April 22

A Full Day of Learning: Earn up to 6.0 AMA PRA Category 1 credits for $129 Montclair, NJ (PRWEB) March 23, 2017 PAINWeekEnd (PWE) Oklahoma City, on April 22 at the Renaissance Oklahoma City Conventio...

E. coli-HUS Lawsuit Filed against The SoyNut Butter Company by Pritzker Hageman Law Firm

Pritzker Hageman, P.A., a national food safety law firm, has filed a lawsuit against The SoyNut Butter Company, based in Glevnview, Illinois, for alleged E. coli contamination of ...

Chlorofields Recalls Asian MIicrogreens Because Of Possible Health Risk

ChloroFields of Lawrence, KS is recalling 20 cases of Asian Microgreens, because they have potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infecti...

LEAD Coalition Urges Congress to Strengthen Alzheimer’s Research, Care and Support; Executive Director Warns President’s Budget Blueprint Would Reverse Progress

Washington, D.C. (PRWEB) March 23, 2017 The Leaders Engaged on Alzheimer’s Disease Coalition (LEAD Coalition) stands with all...

CTD Holdings Initiates Recruitment for U.S. Phase I Clinical Study of Trappsol(R) Cyclo(TM) for Treatment of Niemann-Pick Disease Type C

ALACHUA, FL--(Marketwired - March 23, 2017) - CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, today an...

Oregon teen's mom: Feds should probe fatal police shooting

PORTLAND, Ore. (AP) — The mother of an Oregon teenager who was fatally shot by a Portland police officer is demanding a federal Justice Department investigation into her son's death.

Silence is golden: Suppressing host response to Ebola virus may help to control infection

The Ebola virus causes a severe, often fatal illness when it infects the human body. Initially targeting cells of the immune system called macrophages, white blood cells that absorb and clear away pat...

Events [0 Results]

None

Companies [17 Associated Companies listed on BioPortfolio]

CurePSP

CurePSP is the leading nonprofit advocacy organization focused on prime of life neurodegenerative diseases – a spectrum of fatal brain disorders that often strike during a pe...

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). Voyager is committed to...

Ario Pharma Ltd

ario pharma ltd focusses on the development of drugs for the treatment of respiratory indications. Ario is about to evaluate the anti-tussive properties of XEN-D0501, a potential best-in-class TRPV1...

Agilis Biotherapeutics, LLC

Agilis Biotherapeutics, LLC, is a biotechnology company focused on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affect...

Edge Therapeutics, Inc.

Edge Therapeutics, Inc. is a private, clinical-stage biopharmaceutical company focused on developing and commercializing life-saving hospital products that improve patient outcome...

Takeda Pharmaceuticals U.S.A., Inc. and Affymax, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the ...

Takeda Pharmaceuticals U.S.A. and Affymax, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Development Center Americas, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest p...

Oxyrane UK Limited

WHO WE ARE Oxyrane UK Limited is a biopharmaceutical company dedicated to the development of novel and biosuperior enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class o...

Alpha-Stim

Alpha-Stim is an industry leader in cranial electrotherapy stimulation (CES) devices, providing treatment for anxiety, depression, insomnia and pain, without the side effects comm...

Janssen Alzheimer Immunotherapy

Alzheimer's disease (AD), the most common form of dementia, is a fatal, degenerative brain disease that gradually destroys a person's memory and ability to learn, reason, make judgments, communicate a...

Clinical Trials [560 Associated Clinical Trials listed on BioPortfolio]

Brief Behavioral Treatment for Sleep Problems in IBS Study

Patients with Irritable Bowel Syndrome (IBS) often report more fatigue and sleep disturbances compared to their healthy counterparts and compared to patients with other GI disorders. This ...

The Effect of PDM on Sleep Quality in Older Adults

Insomnia is a chronic mental health condition characterized by difficulty initiating and maintaining sleep with a prevalence of over 50% in Israeli adults ages 65 and above. It is associat...

A Programme for Amyotrophic Lateral Sclerosis Care in Europe

Amyotrophic Lateral Sclerosis (ALS) or else known as Motor Neurone Disease (MND) is a rapidly progressive fatal neurological disease that strikes in the prime of life, and for which there ...

Probiotic (Visbiome) for Gulf War Illness

The overall objective is to determine whether Visbiome will improve 1. intestinal symptoms of Irritable Bowel Syndrome (IBS) and 2. non-intestinal symptoms (fatigue, joint pain, inso...

Internet-based CBT for Insomnia in Chronic Pain

The main goal is to study the effect of therapist-guided internet-delivered cognitive behavioural therapy for insomni comorbid with chronic pain in a clinical sample.

Insomnia and Cognitive Performance in Chronic Pain

The aim of the present study is to examine cognitive function in a patient population with complex chronic pain to test the hypothesis that insomnia severity on its own predicts objective ...

Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults: Phase 1

Insomnia can be a chronic problem that leads to significant daytime fatigue, stress and numerous negative health consequences including depression. Advanced Medical Electronics, in partner...

Virtual Care in CF (VIRTUAL-CF) Study

Cystic fibrosis (CF) is the most common fatal inherited condition in Caucasians, causing recurrent chest infections (pulmonary exacerbations). People with CF experiencing pulmonary exacerb...

Antithrombotic Therapy in Patients Undergoing CIED Surgery - HEMATOMA NO MORE Registry

Hundreds of thousands patients undergo implantation or replacement of cardiac implantable electronic devices (CIEDs) annually in Europe, and up to 50% of these subjects receive antiplatele...

Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder

The main study objective is to assess the content validity and the psychometric characteristics of the Insomnia Daytime Symptoms and Impacts Questionnaire™ (IDSIQ™).

Videos

None available.

Medical and Biotech [MESH] Definitions

An autosomal dominant disorder characterized by degeneration of the THALAMUS and progressive insomnia. It is caused by a mutation in the prion protein (PRIONS).

An acute organic mental disorder induced by cessation or reduction in chronic alcohol consumption. Clinical characteristics include CONFUSION; DELUSIONS; vivid HALLUCINATIONS; TREMOR; agitation; insomnia; and signs of autonomic hyperactivity (e.g., elevated blood pressure and heart rate, dilated pupils, and diaphoresis). This condition may occasionally be fatal. It was formerly called delirium tremens. (From Adams et al., Principles of Neurology, 6th ed, p1175)

Small proteinaceous infectious particles which resist inactivation by procedures that modify NUCLEIC ACIDS and contain an abnormal isoform of a cellular protein which is a major and necessary component. The abnormal (scrapie) isoform is PrPSc (PRPSC PROTEINS) and the cellular isoform PrPC (PRPC PROTEINS). The primary amino acid sequence of the two isoforms is identical. Human diseases caused by prions include CREUTZFELDT-JAKOB SYNDROME; GERSTMANN-STRAUSSLER SYNDROME; and INSOMNIA, FATAL FAMILIAL.

A hypnotic and sedative used in the treatment of INSOMNIA.

A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.

Quick Search
Advertisement
 
review and buy Fatal Insomnia market research data and corporate reports here

Channels Quicklinks